McKesson Corporation
General ticker "MCK" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $86.0B (TTM average)
McKesson Corporation follows the US Stock Market performance with the rate: 39.3%.
Estimated limits based on current volatility of 2.2%: low 949.61$, high 992.43$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-12-01, amount 0.82$ (Y0.35%)
- Total employees count: 51000 (0.0%) as of 2024
- Top business risk factors: Regulatory and compliance, Cybersecurity threats, Manufacturing process failures, Acquisition/divestiture risks, Strategic risks and growth management
- Current price 21.5% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [536.98$, 766.78$]
- 2026-03-31 to 2027-03-31 estimated range: [583.25$, 828.32$]
Financial Metrics affecting the MCK estimates:
- Negative: with PPE of 20.1 at the end of fiscal year the price was high
- Positive: -4.75 < Operating profit margin, % of 1.22
- Positive: 6.64 < Operating cash flow per share per price, % of 7.19
- Negative: Shareholder equity ratio, % of -2.76 <= 19.40
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.43
- Positive: Industry inventory ratio change (median), % of -0.54 <= -0.16
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 4.84
- Positive: -4.43 < Investing cash flow per share per price, % of -0.87
- Negative: 0.01 < Interest expense per share per price, % of 0.30
Short-term MCK quotes
Relationship graph
Long-term MCK plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $276,719.00MM | $308,804.00MM | $359,051.00MM |
| Operating Expenses | $272,338.00MM | $304,895.00MM | $354,679.00MM |
| Operating Income | $4,381.00MM | $3,909.00MM | $4,372.00MM |
| Non-Operating Income | $249.00MM | $-120.00MM | $-13.00MM |
| Interest Expense | $248.00MM | $252.00MM | $256.00MM |
| R&D Expense | $0.00MM | $0.00MM | $91.00MM |
| Income(Loss) | $4,630.00MM | $3,789.00MM | $4,359.00MM |
| Taxes | $905.00MM | $629.00MM | $878.00MM |
| Other Income(Loss) | $-3.00MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $3,560.00MM | $3,002.00MM | $3,295.00MM |
| Stockholders Equity | $-1,857.00MM | $-1,971.00MM | $-2,074.00MM |
| Inventory | $19,691.00MM | $21,139.00MM | $23,001.00MM |
| Assets | $62,320.00MM | $67,443.00MM | $75,140.00MM |
| Operating Cash Flow | $5,159.00MM | $4,314.00MM | $6,085.00MM |
| Capital expenditure | $558.00MM | $687.00MM | $859.00MM |
| Investing Cash Flow | $-542.00MM | $-1,072.00MM | $-733.00MM |
| Financing Cash Flow | $-4,368.00MM | $-3,342.00MM | $-3,965.00MM |
| Earnings Per Share** | $25.23 | $22.54 | $25.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.